ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer
Clinical trial NCT01963052 · COMPLETED
Trial details
- NCT number
- NCT01963052
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-14
- Primary completion
- 2019-07-08
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.